<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03595527</url>
  </required_header>
  <id_info>
    <org_study_id>17.300</org_study_id>
    <nct_id>NCT03595527</nct_id>
  </id_info>
  <brief_title>Universal HIV Screening and Targeted HCV Screening in Emergency Department</brief_title>
  <official_title>Universal HIV Screening and Targeted HCV Screening in Emergency Department</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre hospitalier de l'Université de Montréal (CHUM)</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ministere de la Sante et des Services Sociaux</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Gilead Sciences</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Merck Sharp &amp; Dohme Corp.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre hospitalier de l'Université de Montréal (CHUM)</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cross-sectional study of patients consulting in the emergency room of the Centre hospitalier
      de l'Université de Montréal (CHUM), to assess the implementation of an &quot;opt-out&quot; screening
      program for HIV and HCV and prospective follow-up for 3 months of positive cases.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to evaluate the feasibility of routine HIV and HCV screening
      using an &quot;opt-out&quot; approach at the emergency room of the CHUM and to determine the rate of
      new positive HIV and HCV cases. A sub-analysis will focus more specifically on HCV in the
      Quebec equivalent of &quot;baby boomers&quot; (1945-1975) since this is the group that was targeted in
      the United States. The second phase of this study will evaluate the effectiveness of the
      linkage to the healthcare system for people diagnosed with HIV or HCV and how fast these
      people are taken care of and put on treatment.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">July 10, 2018</start_date>
  <completion_date type="Anticipated">October 10, 2020</completion_date>
  <primary_completion_date type="Actual">October 10, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Prevalence</measure>
    <time_frame>4 months</time_frame>
    <description>Prevalence of HIV and HCV among patients who consult at the ER of the CHUM (overall and undiagnosed cases)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Prevalence among baby-boomers</measure>
    <time_frame>4 months</time_frame>
    <description>Determine the prevalence of new and pre-existing cases of HCV among &quot;baby boomers&quot; (1945 - 1975 years)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Opt-out</measure>
    <time_frame>4 months</time_frame>
    <description>Determine the proportion of patients that opted-out of the routine screening for HIV and HCV at the ER</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Initial workup</measure>
    <time_frame>1 year</time_frame>
    <description>Among patients with a newly positive HIV or HCV test in the ER, determine the proportion of those who attended a first workup appointment at 1 month</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cascade of care</measure>
    <time_frame>1 year</time_frame>
    <description>Determine the proportion that completed certain steps of the HIV and HCV care cascades at 1 or 3 months, ie confirmation of diagnosis (HIV and HCV: 1 month), liver fibrosis assessment (HCV: 3 months), and treatment initiation (HIV: 1 month and HCV: 3 months)</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">4163</enrollment>
  <condition>Hepatitis C</condition>
  <condition>Hiv</condition>
  <arm_group>
    <arm_group_label>Patients consulting in the emergency room</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients consulting in the emergency room.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>HIV and HCV screening</intervention_name>
    <description>HIV test: ARCHITECT HIV Ag/Ab Combo, Abbott HCV test: ARCHITECT Anti-HCV, Abbott</description>
    <arm_group_label>Patients consulting in the emergency room</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Individuals attending the emergency room of the Centre hospitalier de l'Université de
             Montréal

        Exclusion Criteria:

          -  Individuals unable to opt-out due to their psychological or physical condition
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>73 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Centre Hospitalier de l'Université de Montréal</name>
      <address>
        <city>Montréal</city>
        <state>Quebec</state>
        <zip>H2X 3E4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>July 5, 2018</study_first_submitted>
  <study_first_submitted_qc>July 12, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 23, 2018</study_first_posted>
  <last_update_submitted>May 27, 2020</last_update_submitted>
  <last_update_submitted_qc>May 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Screening</keyword>
  <keyword>Linkage to care</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hepatitis C</mesh_term>
    <mesh_term>Emergencies</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

